Literature DB >> 21802344

Differences in p63 expression in SCCHN tumours of different sub-sites within the oral cavity.

Linda Boldrup1, Philip J Coates, Göran Laurell, Karin Nylander.   

Abstract

Squamous cell carcinoma of the head and neck, SCCHN, the sixth most common cancer in the world, comprises tumours of different anatomical sites. The overall survival is low, and there are no good prognostic or predictive markers available. The p53 homologue, p63, plays an important role in development of epithelial structures and has also been suggested to be involved in development of SCCHN. However, most studies on p63 in SCCHN have not taken into account the fact that this group of tumours is heterogeneous in terms of the particular site of origin of the cancer. Mapping and comparing p63 expression levels in tumours and corresponding clinically normal tissue in SCCHN from gingiva, tongue and tongue/floor of the mouth revealed clear differences between these regions. In normal samples from tongue and gingiva, tongue samples showed 2.5-fold higher median p63 expression and also more widespread expression compared to gingival samples. These results emphasise the importance of taking sub-site within the oral cavity into consideration in analyses of SCCHN.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21802344     DOI: 10.1016/j.oraloncology.2011.07.002

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  12 in total

1.  Effect of radiotherapy on expression of hyaluronan and EGFR and presence of mast cells in squamous cell carcinoma of the head and neck.

Authors:  Eva Lindell Jonsson; Karin Nylander; Lars Hallén; Göran Laurell
Journal:  Oncol Lett       Date:  2012-09-11       Impact factor: 2.967

2.  Subsite-based alterations in miR-21, miR-125b, and miR-203 in squamous cell carcinoma of the oral cavity and correlation to important target proteins.

Authors:  Linda Boldrup; Philip J Coates; Magnus Wahlgren; Göran Laurell; Karin Nylander
Journal:  J Carcinog       Date:  2012-11-28

3.  Transcriptional profiling of formalin fixed paraffin embedded tissue: pitfalls and recommendations for identifying biologically relevant changes.

Authors:  Matilda Rentoft; Philip John Coates; Göran Laurell; Karin Nylander
Journal:  PLoS One       Date:  2012-04-17       Impact factor: 3.240

4.  Expression of p16 in squamous cell carcinoma of the mobile tongue is independent of HPV infection despite presence of the HPV-receptor syndecan-1.

Authors:  N Sgaramella; P J Coates; K Strindlund; L Loljung; G Colella; G Laurell; R Rossiello; L L Muzio; C Loizou; G Tartaro; K Olofsson; K Danielsson; R Fåhraeus; K Nylander
Journal:  Br J Cancer       Date:  2015-06-09       Impact factor: 7.640

5.  Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue.

Authors:  Matilda Rentoft; Philip John Coates; Lotta Loljung; Torben Wilms; Göran Laurell; Karin Nylander
Journal:  Tumour Biol       Date:  2014-01-07

6.  Evidence that circulating proteins are more promising than miRNAs for identification of patients with squamous cell carcinoma of the tongue.

Authors:  Linda Boldrup; Giuseppe Troiano; Xiaolian Gu; Philip Coates; Robin Fåhraeus; Torben Wilms; Lena Norberg-Spaak; Lixiao Wang; Karin Nylander
Journal:  Oncotarget       Date:  2017-09-30

7.  Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.

Authors:  Zehang Zhuang; Nan Xie; Jing Hu; Pei Yu; Cheng Wang; Xingxue Hu; Xiaozhe Han; Jinsong Hou; Hongzhang Huang; Xiqiang Liu
Journal:  Oncotarget       Date:  2017-03-28

8.  Site-specific gene expression patterns in oral cancer.

Authors:  Gesche Frohwitter; Horst Buerger; Eberhard Korsching; Paul J van Diest; Johannes Kleinheinz; Thomas Fillies
Journal:  Head Face Med       Date:  2017-05-10       Impact factor: 2.151

9.  Gene expression changes in tumor free tongue tissue adjacent to tongue squamous cell carcinoma.

Authors:  Linda Boldrup; Xiaolian Gu; Philip J Coates; Lena Norberg-Spaak; Robin Fahraeus; Göran Laurell; Torben Wilms; Karin Nylander
Journal:  Oncotarget       Date:  2017-03-21

10.  Levels of MUC1 in tumours and serum of patients with different sub-types of squamous cell carcinoma of the head and neck.

Authors:  Linda Boldrup; Philip Coates; Xiaolian Gu; Lixiao Wang; Robin Fåhraeus; Torben Wilms; Nicola Sgaramella; Jonathan Baumgarth; Lena Norberg-Spaak; Karin Nylander
Journal:  Oncol Lett       Date:  2020-06-17       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.